169 related articles for article (PubMed ID: 31556724)
1.
Paço A; Freitas R
Epigenomics; 2019 Oct; 11(13):1539-1552. PubMed ID: 31556724
[TBL] [Abstract][Full Text] [Related]
2. Epigenetic drugs as pleiotropic agents in cancer treatment: biomolecular aspects and clinical applications.
Sigalotti L; Fratta E; Coral S; Cortini E; Covre A; Nicolay HJ; Anzalone L; Pezzani L; Di Giacomo AM; Fonsatti E; Colizzi F; Altomonte M; Calabrò L; Maio M
J Cell Physiol; 2007 Aug; 212(2):330-44. PubMed ID: 17458893
[TBL] [Abstract][Full Text] [Related]
3. Methylation in
Paço A; de Bessa Garcia SA; Freitas R
Cells; 2020 Jul; 9(7):. PubMed ID: 32635388
[No Abstract] [Full Text] [Related]
4. Remodeling epigenetic modifications at tumor suppressor gene promoters with bovine oocyte extract.
Wang Z; Yue Y; Han P; Sa R; Ren X; Wang J; Bai H; Yu H
Cytotherapy; 2013 Sep; 15(9):1164-73. PubMed ID: 23800731
[TBL] [Abstract][Full Text] [Related]
5. Epigenetic targeting of the Nanog pathway and signaling networks during chemical carcinogenesis.
Tommasi S; Zheng A; Yoon JI; Besaratinia A
Carcinogenesis; 2014 Aug; 35(8):1726-36. PubMed ID: 24480805
[TBL] [Abstract][Full Text] [Related]
6. Epigenetic blockade of neoplastic transformation by bromodomain and extra-terminal (BET) domain protein inhibitor JQ-1.
Zhang C; Su ZY; Wang L; Shu L; Yang Y; Guo Y; Pung D; Bountra C; Kong AN
Biochem Pharmacol; 2016 Oct; 117():35-45. PubMed ID: 27520485
[TBL] [Abstract][Full Text] [Related]
7. Chromosome 7 gain and DNA hypermethylation at the HOXA10 locus are associated with expression of a stem cell related HOX-signature in glioblastoma.
Kurscheid S; Bady P; Sciuscio D; Samarzija I; Shay T; Vassallo I; Criekinge WV; Daniel RT; van den Bent MJ; Marosi C; Weller M; Mason WP; Domany E; Stupp R; Delorenzi M; Hegi ME
Genome Biol; 2015 Jan; 16(1):16. PubMed ID: 25622821
[TBL] [Abstract][Full Text] [Related]
8. DNA and histone methylation in gastric carcinogenesis.
Calcagno DQ; Gigek CO; Chen ES; Burbano RR; Smith Mde A
World J Gastroenterol; 2013 Feb; 19(8):1182-92. PubMed ID: 23482412
[TBL] [Abstract][Full Text] [Related]
9. Promoter Methylation Analysis Reveals That KCNA5 Ion Channel Silencing Supports Ewing Sarcoma Cell Proliferation.
Ryland KE; Hawkins AG; Weisenberger DJ; Punj V; Borinstein SC; Laird PW; Martens JR; Lawlor ER
Mol Cancer Res; 2016 Jan; 14(1):26-34. PubMed ID: 26573141
[TBL] [Abstract][Full Text] [Related]
10. Human DNA (cytosine-5)-methyltransferases: a functional and structural perspective for epigenetic cancer therapy.
Rondelet G; Wouters J
Biochimie; 2017 Aug; 139():137-147. PubMed ID: 28600135
[TBL] [Abstract][Full Text] [Related]
11. DNA methylation and histone modifications in patients with cancer: potential prognostic and therapeutic targets.
Herranz M; Esteller M
Methods Mol Biol; 2007; 361():25-62. PubMed ID: 17172706
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of HOX genes is prevalent in Ewing sarcoma and is associated with altered epigenetic regulation of developmental transcription programs.
Svoboda LK; Harris A; Bailey NJ; Schwentner R; Tomazou E; von Levetzow C; Magnuson B; Ljungman M; Kovar H; Lawlor ER
Epigenetics; 2014 Dec; 9(12):1613-25. PubMed ID: 25625846
[TBL] [Abstract][Full Text] [Related]
13. Epigenetic biomarkers for human cancer: the time is now.
Mulero-Navarro S; Esteller M
Crit Rev Oncol Hematol; 2008 Oct; 68(1):1-11. PubMed ID: 18430583
[TBL] [Abstract][Full Text] [Related]
14. Molecular Mechanisms of Epigenetic Regulators as Activatable Targets in Cancer Theranostics.
Li Y; Li Z; Zhu WG
Curr Med Chem; 2019; 26(8):1328-1350. PubMed ID: 28933282
[TBL] [Abstract][Full Text] [Related]
15. [Targeted epigenetic therapy of cancer. Achievements and perspectives].
Valdespino-Gómez VM; Valdespino-Castillo VE
Cir Cir; 2012; 80(5):470-80. PubMed ID: 23351455
[TBL] [Abstract][Full Text] [Related]
16. Change in gene expression profiles of secreted frizzled-related proteins (SFRPs) by sodium butyrate in gastric cancers: induction of promoter demethylation and histone modification causing inhibition of Wnt signaling.
Shin H; Kim JH; Lee YS; Lee YC
Int J Oncol; 2012 May; 40(5):1533-42. PubMed ID: 22246241
[TBL] [Abstract][Full Text] [Related]
17. The Roles of miR-26, miR-29, and miR-203 in the Silencing of the Epigenetic Machinery during Melanocyte Transformation.
Gasque Schoof CR; Izzotti A; Jasiulionis MG; Vasques Ldos R
Biomed Res Int; 2015; 2015():634749. PubMed ID: 26618174
[TBL] [Abstract][Full Text] [Related]
18. Cucurbitacin B Alters the Expression of Tumor-Related Genes by Epigenetic Modifications in NSCLC and Inhibits NNK-Induced Lung Tumorigenesis.
Shukla S; Khan S; Kumar S; Sinha S; Farhan M; Bora HK; Maurya R; Meeran SM
Cancer Prev Res (Phila); 2015 Jun; 8(6):552-62. PubMed ID: 25813524
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic inactivation of tumour suppressor coding and non-coding genes in human cancer: an update.
Llinàs-Arias P; Esteller M
Open Biol; 2017 Sep; 7(9):. PubMed ID: 28931650
[TBL] [Abstract][Full Text] [Related]
20. Concerted changes in transcriptional regulation of genes involved in DNA methylation, demethylation, and folate-mediated one-carbon metabolism pathways in the NCI-60 cancer cell line panel in response to cancer drug treatment.
Krushkal J; Zhao Y; Hose C; Monks A; Doroshow JH; Simon R
Clin Epigenetics; 2016; 8():73. PubMed ID: 27347216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
